Use of depot medroxyprogesterone acetate (DMPA) weakens both innate and adaptive immune responses to HIV type 1 (HIV-1) and, therefore, reduces host resistance to the infection, new data suggest. DMPA ...

Expert Rev of Obstet Gynecol. 2010;5(6):673-686. Each year worldwide, over 380,000 women die from pregnancy and pregnancy-related causes. If contraception were made available to unprotected women, ...

Women who used an injectable contraceptive called DMPA were more likely to acquire HIV than women using a similar product called NET-EN, according to a secondary analysis of data from a large HIV ...

DMPA SC does not protect against HIV infection (AIDS) or other sexually transmitted diseases. Injection site reactions such as injection site pain, injection site tenderness, injection site nodules, ...

A new review of research suggests that women using the injectable contraceptive depot-medroxyprogesterone acetate or DMPA might be at higher risk of HIV infection by as much at 40%. Medical ...

Women who used an injectable contraceptive called DMPA were more likely to acquire HIV than women using a similar product called NET-EN, according to a secondary analysis of data from a large HIV ...

A non-governmental research organisation, Akena Plus Health, has dispelled the misconception that the Depot-Medroxyprogesterone Acetate-Sub Cutaneous, an all-in-one contraceptive that puts women in ...